Summary of the evidence
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Clinical bottom line
Hypertonic saline appears to be effective in reducing intracranial pressure after traumatic brain injury in dogs in experimental studies.
ICP after resuscitation with hypertonic saline was lower than after LRS while restoring systolic blood pressure and cardiac output to the same level.
Limitations:
 experimental study  no brain injury or increased ICP to begin with  small number of cases
Gunnar (1988)
Population: Laboratory Beagles Study design: Experimental controlled study.
Outcome studied: Continuous ICP monitoring, blood brain barrier function assessed by degree of Evans Blue staining and cerebral oedema formation assessed by wet brain weights.
Main findings: (relevant to PICO question):
3% hypertonic saline caused lower intracranial pressure and less cerebral oedema than either 0.9% saline or dextran-40, but blood brain barrier integrity is not restored.
Limitations:
 experimental study  no survivors to assess clinical outcome  short term study of only 3h duration  small number of cases was attempted, after this, normal saline was given at a rate to maintain CVP at 10mmHg.
Study design: Experimental uncontrolled study.
Outcome studied: Cerebral blood flow and ICP were measured at baseline, at the end of the shock period, during resuscitation and after resuscitation.
Main findings: (relevant to PICO question):
Though the intracranial pressure was lower in the hypertonic saline group, cerebral blood flow did not vary.
Limitations:
 experimental study  no assessment of clinical outcome  short term study of only 3h duration  small number of cases
Pinto (2006)
Population: Crossbreed dogs
Sample size: 15
Intervention details: 20 minutes after experimentally induced haemorrhagic shock via bleeding to MAP of 40mmHg and simulated traumatic brain injury via fluid percussion and epidural balloon, volume was replaced with 3% hypertonic saline (8ml/kg over 10 min) or LRS (16ml/kg over 10 ml) in five dogs each. 20 minutes later shed blood and more of the previous fluids were given to a haematocrit of 30% and a MAP of >70mm Hg. A control group of five received no fluids at either point. After 60 minutes the epidural balloon was deflated in the treatment groups.
Study design: Experimental, randomised, controlled study.
Outcome studied: MAP, cardiac index, ICP, CPP, biochemistry and blood gases.
Main findings: (relevant to PICO question):
3% hypertonic saline results in lower ICP than LRS even though CPP remains similar. Hypertonic saline also causes higher serum sodium concentration and osmolarity than LRS.
Limitations:
 experimental study  no clinical outcome described  small number of cases
Sharma (2015)
Population: Client-owned dogs with head trauma <5 days before hospital admission.
Sample size: 72
Intervention details: No specific interventions, clinical records were analysed.
Study design: Retrospective descriptive study, based on medical records. Outcome studied: The prognostic value of clinical and laboratory variables, scoring systems and treatments (such as hypertonic saline) in dogs with head trauma was calculated.
Main findings: (relevant to PICO question):
Hypertonic saline administration was associated with lower likelihood of survival to discharge (8 survivors, 4 nonsurvivors).
Limitations:
 retrospective case study  no control group  multiple parameters observed, prognostic value of individual variables on their own hard to quantify  small number of cases
Pinto (2015)
Sample size: 15
Intervention details: 20 minutes after experimentally induced haemorrhagic shock via bleeding to MAP of 40mmHg and simulated traumatic brain injury via fluid percussion and epidural balloon, volume was replaced with 3% hypertonic saline (8ml/kg over 10 min) or LRS (16ml/kg over 10 min) in 5 dogs each. 20 minutes later shed blood and more of the previous fluids were given to a haematocrit of 30% and a MAP of >70mm Hg. A control group of five dogs received no fluids at either point. After 1h the epidural balloon was deflated in the treatment groups. All dogs were euthanised after 3h and the brains removed, visually assessed and further analysed after tissue fixation.
Study design: Experimental controlled study.
Outcome studied: MAP and ICP were measured, changes in pupil state were assessed every 10 minutes, macroscopic and microscopic brain pathology and prostaglandoid production were assessed.
Main findings: (relevant to PICO question):
ICP was the lowest in the hypertonic saline cases during the initial 60 minutes. In brains that had received hypertonic saline, no cerebral oedema was identified macroscopically and ischaemic lesions were less evident. In cases with pupil changes, the pupils reversed to normal sooner in the hypertonic saline group.
Limitations:
 experimental study  no survivors to assess clinical outcome  short term study of only 3h duration  macroscopic assessment for cerebral oedema only  small number of cases
Appraisal, application and reflection
The purpose of this Knowledge Summary was to look at the evidence for the use of hypertonic saline in total pages: 8 reducing intracranial pressure in head trauma patients.
The experimental studies available in dogs seem to indicate that hypertonic saline might have a good effect on increased intracranial pressure after traumatic brain injury while achieving desirable haemodynamic parameters.
There are no controlled clinical studies that evaluate the use of hypertonic saline as an independent variable. In the descriptive study from Sharma & Holowaychuck (2015) the decision to use hypertonic saline was the clinician's, and sometimes made after other treatment options had been unsuccessful. The choice to use hypertonic saline appears mostly to have been made in very severe cases, which may explain the negative predictive value of hypertonic saline use on survival until discharge.
In conclusion, hypertonic saline appears to be effective in reducing intracranial pressure after traumatic brain injury in experimental studies. How effective its use might be in clinical settings cannot be answered.
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